Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Confirming Alignment on the Cerebral Palsy Clinical Trial Plan at the Pre-IND Meeting with U.S. FDA (SQ-SHED's Overseas Development)
Interim Results of SHED Clinical Study for Children with Cerebral Palsy Disclosed by Nagoya University
Financial Results for FY2025 Q2
Summary of Consolidated Financial Results for 2Q of the Fiscal Year Ended March 31, 2026
"Treg" with "SHED" Toward the Development of an Innovative Immune Cell Therapy -Joint Research Agreement with Tokyo University of Science-
Toward a New Infertility Treatment Utilizing SHED - Commencement of Joint Research with LYMPHOGENiX (UK) -
SHED Clinical Study for Cerebral Palsy Data Safety Monitoring Board Confirms "No Safety Concerns"
Agreement in Principle to Establish a Joint Venture Alliance for the Development of Domestic Manufacturing Facility for Biosimilars
Execution of Agreements regarding the Joint Development of Biosimilars for Specified Products
Publication of Research Paper on the Application of SHED in the Treatment of Peripheral Nerve Injuries
Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2026
Financial Results for FY2025 Q1